79 related articles for article (PubMed ID: 26868435)
1. A hidden aggregation-prone structure in the heart of hypoxia inducible factor prolyl hydroxylase.
Hadi-Alijanvand H; Proctor EA; Ding F; Dokholyan NV; Moosavi-Movahedi AA
Proteins; 2016 May; 84(5):611-23. PubMed ID: 26868435
[TBL] [Abstract][Full Text] [Related]
2. Thermal unfolding pathway of PHD2 catalytic domain in three different PHD2 species: computational approaches.
Hadi-Alijanvand H; Proctor EA; Goliaei B; Dokholyan NV; Moosavi-Movahedi AA
PLoS One; 2012; 7(10):e47061. PubMed ID: 23077544
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and mRNA expression of HIF-prolyl hydroxylase-2 (phd2) in hypoxia-sensing pathways from Megalobrama amblycephala.
Wang H; Huang C; Chen N; Zhu K; Chen B; Wang W; Wang H
Comp Biochem Physiol B Biochem Mol Biol; 2015 Aug; 186():28-35. PubMed ID: 25868626
[TBL] [Abstract][Full Text] [Related]
4. Computational analysis of prolyl hydroxylase domain-containing protein 2 (PHD2) mutations promoting polycythemia insurgence in humans.
Minervini G; Quaglia F; Tosatto SC
Sci Rep; 2016 Jan; 6():18716. PubMed ID: 26754054
[TBL] [Abstract][Full Text] [Related]
5. The Zinc Finger of Prolyl Hydroxylase Domain Protein 2 Is Essential for Efficient Hydroxylation of Hypoxia-Inducible Factor α.
Arsenault PR; Song D; Chung YJ; Khurana TS; Lee FS
Mol Cell Biol; 2016 Sep; 36(18):2328-43. PubMed ID: 27325674
[TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
[TBL] [Abstract][Full Text] [Related]
7. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation.
Takeda K; Fong GH
Hypertension; 2007 Jan; 49(1):178-84. PubMed ID: 17101841
[TBL] [Abstract][Full Text] [Related]
8. Activation of the hypoxia-inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice.
Nunomiya A; Shin J; Kitajima Y; Dan T; Miyata T; Nagatomi R
Acta Physiol (Oxf); 2017 May; 220(1):99-112. PubMed ID: 27393382
[TBL] [Abstract][Full Text] [Related]
9. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
10. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
HoWangYin KY; Loinard C; Bakker W; Guérin CL; Vilar J; d'Audigier C; Mauge L; Bruneval P; Emmerich J; Lévy BI; Pouysségur J; Smadja DM; Silvestre JS
Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
[TBL] [Abstract][Full Text] [Related]
11. Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors.
Deng G; Zhao B; Ma Y; Xu Q; Wang H; Yang L; Zhang Q; Guo TB; Zhang W; Jiao Y; Cai X; Zhang J; Liu H; Guan X; Lu H; Xiang J; Elliott JD; Lin X; Ren F
Bioorg Med Chem; 2013 Nov; 21(21):6349-58. PubMed ID: 24055079
[TBL] [Abstract][Full Text] [Related]
12. Screening prolyl hydroxylase domain 2 inhibitory activity of traditional Chinese medicine by CZE-UV.
Zhang Y; Zhao M; Wang CB; Wang Y; Nsanzamahoro S; Zhu LL; Wang WF; Yang JL
Electrophoresis; 2022 Aug; 43(15):1601-1610. PubMed ID: 35405037
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin from bovine colostrum regulates prolyl hydroxylase 2 activity and prevents prion protein-mediated neuronal cell damage via cellular prion protein.
Park YG; Moon JH; Park SY
Neuroscience; 2014 Aug; 274():187-97. PubMed ID: 24875174
[TBL] [Abstract][Full Text] [Related]
14. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.
Arsenault PR; Pei F; Lee R; Kerestes H; Percy MJ; Keith B; Simon MC; Lappin TRJ; Khurana TS; Lee FS
J Biol Chem; 2013 Nov; 288(47):33571-33584. PubMed ID: 24121508
[TBL] [Abstract][Full Text] [Related]
15. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
[TBL] [Abstract][Full Text] [Related]
16. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
[TBL] [Abstract][Full Text] [Related]
17. Increased Turnover at Limiting O2 Concentrations by the Thr(387) → Ala Variant of HIF-Prolyl Hydroxylase PHD2.
Pektas S; Taabazuing CY; Knapp MJ
Biochemistry; 2015 May; 54(18):2851-7. PubMed ID: 25857330
[TBL] [Abstract][Full Text] [Related]
18. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
[TBL] [Abstract][Full Text] [Related]
19. Small-molecules that covalently react with a human prolyl hydroxylase - towards activity modulation and substrate capture.
Bush JT; Leśniak RK; Yeh TL; Belle R; Kramer H; Tumber A; Chowdhury R; Flashman E; Mecinović J; Schofield CJ
Chem Commun (Camb); 2019 Jan; 55(8):1020-1023. PubMed ID: 30452037
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
